1993
DOI: 10.1111/j.1471-0528.1993.tb15282.x
|View full text |Cite
|
Sign up to set email alerts
|

Outpatient investigation of postmenopausal bleeding

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
12
0
1

Year Published

1995
1995
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(13 citation statements)
references
References 7 publications
0
12
0
1
Order By: Relevance
“…In the absence of such reporting, the studies were classified as unclear in their reporting of blinding. We classified the reference standard into three groups: those examining hysterectomy specimens or undergoing direct biopsy under hysteroscopic vision (1); those examining specimens from blind Dilatation and Curettage (D & C) under general anesthesia (2); and those obtained by outpatient endometrial biopsy (3). Description of follow up to verify outcome was sought on all women recruited into the study.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…In the absence of such reporting, the studies were classified as unclear in their reporting of blinding. We classified the reference standard into three groups: those examining hysterectomy specimens or undergoing direct biopsy under hysteroscopic vision (1); those examining specimens from blind Dilatation and Curettage (D & C) under general anesthesia (2); and those obtained by outpatient endometrial biopsy (3). Description of follow up to verify outcome was sought on all women recruited into the study.…”
Section: Methodsmentioning
confidence: 99%
“…Traditionally, dilatation and curettage is routinely used to obtain a histologic diagnosis. Recently, less invasive outpatient diagnostic investigations have been advocated, such as hysteroscopy (2,3) and the measurement of endometrial thickness by pelvic ultrasonography (2)(3)(4)(5)(6). The accuracy of these tests in C Acta Obstet Gynecol Scand 81 (2002) predicting endometrial hyperplasia and endometrial carcinoma is a subject of continuing debate (7)(8)(9)(10)(11)(12).…”
mentioning
confidence: 99%
“…However the citing of high false-negative rates (10%) of curettage procedures and consequently their limitation of accuracy may be explained by the fact that especially in enlarged uteri less than half the uterine cavity is curetted in 60% of the cases (45). This high rate of false-negative results is a problem which also extends to the other blind endometrial sampling methods (46). If blind endometrial sampling fails to yield sufficient tissue for histologic examination or if the histologic finding does not show evidence of endometrial disease, the clinician should consider the possibility of insufficient sample or of a missed lesion.…”
Section: Discussionmentioning
confidence: 93%
“…Postmenopozal kanamalı hastalarda kanama nedenleri arasında atrofik endometriyum (%60-80), eksojen hormon tedavisi (%15-25), endometriyal hiperplazi (%5-10), endometriyal/servikal polip (%2-12) ve endometriyum kanseri (%10) yer almaktadır. Bunun yanı sıra servisit, atrofik vajinit, vulva, vajen ve serviks kanserleri, uterus sarkomları ve over kanserlerine bağlı kanamalar da görülebilir [14]. Hastamızda öncelikle basit atipisiz endometrial hiperplazi kanama nedeni olarak ortaya çıkmış, hormon tedavisine bir süre cevap veren hastada endometrial polipe bağlı tekrarlayan kanamaların artması nedeniyle malignitenin ekarte edilmesi amacıyla total abdominal histerektomi ve bilateral salpingo-ooferektomi uygulanmıştır.…”
Section: Discussionunclassified